Vaxart
VXRT
#9378
Rank
โ‚ฌ75.91 M
Marketcap
0,32ย โ‚ฌ
Share price
1.29%
Change (1 day)
-47.02%
Change (1 year)

Revenue for Vaxart (VXRT)

Revenue in 2025 (TTM): โ‚ฌ72.02 Million

According to Vaxart's latest financial reports the company's current revenue (TTM ) is โ‚ฌ68.99 Million. In 2024 the company made a revenue of โ‚ฌ27.57 Million an increase over the revenue in the year 2023 that were of โ‚ฌ6.67 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Vaxart from 1996 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ72.02 M161.15%
2024 โ‚ฌ27.57 M313.18%
2023 โ‚ฌ6.67 M6591.72%
2022 โ‚ฌ0.09 M-87.34%
2021 โ‚ฌ0.78 M-76.06%
2020 โ‚ฌ3.28 M-62.63%
2019 โ‚ฌ8.8 M142.15%
2018 โ‚ฌ3.63 M-44.08%
2017 โ‚ฌ6.5 M-29.51%
2016 โ‚ฌ9.22 M-24.75%
2015 โ‚ฌ12.25 M-71.61%
2014 โ‚ฌ43.16 M13.44%
2013 โ‚ฌ38.05 M309.85%
2012 โ‚ฌ9.28 M-18.74%
2011 โ‚ฌ11.42 M-56.58%
2010 โ‚ฌ26.31 M259.47%
2009 โ‚ฌ7.32 M
2006 โ‚ฌ68.1 M-19.05%
2005 โ‚ฌ84.13 M-36.51%
2004 โ‚ฌ0.13 B-5.51%
2003 โ‚ฌ0.14 B-25.19%
2002 โ‚ฌ0.18 B-29.5%
2001 โ‚ฌ0.26 B9.49%
2000 โ‚ฌ0.24 B4.6%
1999 โ‚ฌ0.23 B13.33%
1998 โ‚ฌ0.20 B6.3%
1997 โ‚ฌ0.19 B-4.63%
1996 โ‚ฌ0.20 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
NRC Health
NRC
โ‚ฌ0.11 B 72.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
N/AN/A Bahamas